Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00233428 · ClinicalTrials.gov registry record
Study to Determine Racial and Gender Differences in Platelet Aggregation
A clinical trial, sponsored by Texas Tech University Health Sciences Center.
- Completed
- Registry status
- 60
- Enrollment target
NCT00233428: Completed study, sponsored by Texas Tech University Health Sciences Center.
NCT00233428 is a clinical trial that has completed, run by Texas Tech University Health Sciences Center. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00233428 has completed, sponsored by Texas Tech University Health Sciences Center.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to see if there is a racial and/or gender difference in platelet aggregation.
Interventions
- PROCEDURE Blood Draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2005-05 |
| Est. Completion | 2006-05 |
What the finished NCT00233428 record still lists
NCT00233428 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Blood Draw is the first listed.
NCT00233428 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00233428 about?
NCT00233428 is a clinical study titled "Study to Determine Racial and Gender Differences in Platelet Aggregation". The purpose of this study is to see if there is a racial and/or gender difference in platelet aggregation.
What is the current status of trial NCT00233428?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2005-05. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00233428?
The interventions under investigation include: Blood Draw (PROCEDURE).
Who is sponsoring clinical trial NCT00233428?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia